Abstract: The present disclosure is directed to linear polyphosphazene compounds, including compounds represented by the following chemical formula 1. wherein n can an integer from 1 to 300; MPEG can represent methoxy poly(ethylene glycol) with a molecular weight of 350 to 1000; S can be a space group selected from the group consisting of lysine, arginine, glutamine, asparagine, tyrosine, lysine containing oligopeptide, arginine containing oligopeptide, glutamine containing oligopeptide, asparagine containing oligopeptide, tyrosine containing oligopeptide, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol, and amino-hexanol; 1 may equal to 0-0.9 and m may equal to 0.1-1.

Abstract: An organic light emitting display device includes a first transistor including a first active region and a first gate electrode disposed on the first active region, a third transistor including a third lower gate electrode disposed on the first gate electrode, a third active region disposed on the third lower gate electrode, and a third upper gate electrode disposed on the third active region, and a fourth transistor including a fourth active region disposed in the same layer as the first active region and a fourth gate electrode disposed on the fourth active region. The first transistor is a first-type transistor, and the fourth transistor is a second-type transistor different from the first-type transistor.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: A display device includes a plurality of pixel electrodes spaced apart from each other, in which each pixel electrode includes a central part and a peripheral part surrounding the central part, a pixel defining layer disposed on the plurality of pixel electrodes and including an overlap part overlapping the peripheral part when viewed in a plan view, and a lateral side to define a pixel opening exposing the central part, in which a portion of the overlap part has an undercut, a light emitting material disposed on the central part exposed through the pixel opening, and a common electrode including a first part disposed on the light emitting material on the central part and a second part disposed on the pixel defining layer, in which the first part is disconnected from the second part along the undercut portion.

Abstract: The present invention relates to a system for providing sound source reproduction information and has an object to provide a system for providing sound source reproduction information, in which the sound source reproduction information is provided for each user in the order of their distance from each user, and a user selectively browses sound source information of other users reproduced in the vicinity thereof and generates a synchronization request signal for the sound source information, such that reproduction of the sound source may be synchronized between users without performing any settings with each other.

Abstract: The present invention relates to a system for providing sound source reproduction information and has an object to provide a system for providing sound source reproduction information, in which the sound source reproduction information is provided for each user in the order of their distance from each user, and a user selectively browses sound source information of other users reproduced in the vicinity thereof and generates a synchronization request signal for the sound source information, such that reproduction of the sound source may be synchronized between users without performing any settings with each other.

Abstract: The present invention provides an apparatus, system and method for reproducing data in groups. According to the apparatus, system and method for reproducing data in groups, some piece of data of sound source data that is already being reproduced through a specific terminal or external speaker is input through a microphone and compared with the entire data of the sound source data, thus to identify a current reproduction point, and synchronize the reproduction point with sound source data being played externally, thereby reproducing the sound source data at the same time.

Abstract: The present invention provides an apparatus, system and method for reproducing data in groups. According to the apparatus, system and method for reproducing data in groups, some piece of data of sound source data that is already being reproduced through a specific terminal or external speaker is input through a microphone and compared with the entire data of the sound source data, thus to identify a current reproduction point, and synchronize the reproduction point with sound source data being played externally, thereby reproducing the sound source data at the same time.

Abstract: An organic light emitting display device includes a first transistor including a first active region and a first gate electrode disposed on the first active region, a third transistor including a third lower gate electrode disposed on the first gate electrode, a third active region disposed on the third lower gate electrode, and a third upper gate electrode disposed on the third active region, and a fourth transistor including a fourth active region disposed in the same layer as the first active region and a fourth gate electrode disposed on the fourth active region. The first transistor is a first-type transistor, and the fourth transistor is a second-type transistor different from the first-type transistor.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present disclosure provides a carrier composition for eye drops in which a substance to be delivered is loaded in a carrier, wherein the substance to be delivered includes one or more selected from the group consisting of an anti-inflammatory agent, a glaucoma treatment agent, a calcium channel blocker (CCB), an NMDA-receptor blocker, an antioxidant, a nitric oxide synthase inhibitor, a heat shock protein (HSP), a cystinosis treatment agent, and an antibiotic, the carrier has a spherical shape, the carrier includes a multilayer shell in a region ranging from the center to the surface of the carrier, the multilayer shell includes a core located in the center of the carrier and including a carboxymethyl cellulose (CMC)-based hydrogel having a degree of substitution (D.S.) of 0.9, a first shell located on the surface of the core and including a CMC-based hydrogel having a degree of substitution of 0.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present disclosure provides a carrier composition for eye drops in which a substance to be delivered is loaded in a carrier, wherein the substance to be delivered includes one or more selected from the group consisting of an anti-inflammatory agent, a glaucoma treatment agent, a calcium channel blocker (CCB), an NMDA-receptor blocker, an antioxidant, a nitric oxide synthase inhibitor, a heat shock protein (HSP), a cystinosis treatment agent, and an antibiotic, the carrier has a spherical shape, the carrier includes a multilayer shell in a region ranging from the center to the surface of the carrier, the multilayer shell includes a core located in the center of the carrier and including a carboxymethyl cellulose (CMC)-based hydrogel having a degree of substitution (D.S.) of 0.9, a first shell located on the surface of the core and including a CMC-based hydrogel having a degree of substitution of 0.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.

Abstract: The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.